FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $780 | -33.0% | 1,419,013 | 0.0% | 0.68% | -38.1% |
| Q1 2023 | $1,164 | +116.0% | 1,419,013 | +72.5% | 1.10% | +93.0% |
| Q4 2022 | $539 | -99.9% | 822,513 | +3.8% | 0.57% | -25.4% |
| Q3 2022 | $682,000 | +6.7% | 792,513 | +4.1% | 0.76% | +15.4% |
| Q2 2022 | $639,000 | +356.4% | 760,992 | +640.2% | 0.66% | +474.8% |
| Q1 2022 | $140,000 | -45.5% | 102,805 | 0.0% | 0.12% | -33.5% |
| Q4 2021 | $257,000 | -38.1% | 102,805 | -20.2% | 0.17% | -32.7% |
| Q3 2021 | $415,000 | -9.8% | 128,805 | 0.0% | 0.26% | -1.5% |
| Q2 2021 | $460,000 | +2.4% | 128,805 | +1.2% | 0.26% | +0.4% |
| Q1 2021 | $449,000 | – | 127,330 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |